Login Register Cart 0
Generic placeholder image

Current Medical Imaging

Editor-in-Chief

ISSN (Print): 1573-4056
ISSN (Online): 1875-6603

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Usefulness of High-Resolution Computed Tomography in Early Diagnosis of Patients with Suspected COVID-19

Author(s): Alma Angélica Ronzón-Ronzón, Brenda Aida Acevedo Salinas, José Agustín Mata Chapol, Dalia María Soto Valdez, Silvia Refugio Sánchez, Briceida López Martínez, Israel Parra-Ortega and Jessie Zurita-Cruz*

Volume 18, Issue 14, 2022

Published on: 11 August, 2022

Article ID: e060622205670 Pages: 7

DOI: 10.2174/1573405618666220606161924

Price: $65

conference banner
Abstract

Background: Diagnosis of coronavirus disease 2019 (COVID-19) is mainly based on molecular testing. General population studies have shown that chest Computed Tomography (CT) can also be useful.

Objective: The study aims to examine the usefulness of high-resolution chest CT for early diagnosis of patients with suspected COVID-19.

Design And Setting: This is a cross-sectional study from May 1, 2020, to August 31, 2021, at the COVID Hospital, Mexico City.

Methods: This study examined the clinical, high-resolution chest CT imaging, and laboratory data of 160 patients who were suspected to have COVID-19. Patients with positive Reverse Transcription- Polymerase Chain Reaction (RT-PCR) testing and those with negative RT-PCR testing but clinical data compatible with COVID-19 and positive antibody testing were considered to have COVID-19 (positive). Sensitivity and specificity of CT for diagnosis of COVID-19 were calculated. p < 0.05 was considered significant.

Results: Median age of 160 study patients was 58 years. The proportion of patients with groundglass pattern was significantly higher in patients with COVID-19 than in those without COVID (65.1% versus 0%; P = 0.005). COVID-19 was ruled out in sixteen (11.1%). Only four of the 132 patients diagnosed with COVID-19 (3.0%) did not show CT alterations (p < 0.001). Sensitivity and specificity of CT for COVID-19 diagnosis were 96.7% and 42.8%, respectively.

Conclusions: Chest CT can identify patients with COVID-19, as characteristic disease patterns are observed on CT in the early disease stage.

Keywords: Diagnosis, SARS-CoV-2, COVID-19, computed tomography, sensitivity, specificity.

Graphical Abstract

[1]
Colaneri M, Sacchi P, Zuccaro V, et al. Clinical characteristics of coronavirus disease (COVID-19) early findings from a teaching hospital in Pavia, North Italy, 21 to 28 February 2020. Euro Surveill 2020; 25(16): 2000460.
[http://dx.doi.org/10.2807/1560-7917.ES.2020.25.16.2000460] [PMID: 32347201]
[2]
Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395(10223): 497-506.
[http://dx.doi.org/10.1016/S0140-6736(20)30183-5] [PMID: 31986264]
[3]
Hilgenfeld R, Peiris M. From SARS to MERS: 10 years of research on highly pathogenic human coronaviruses. Antiviral Res 2013; 100(1): 286-95.
[http://dx.doi.org/10.1016/j.antiviral.2013.08.015] [PMID: 24012996]
[4]
Cai J, Sun W, Huang J, Gamber M, Wu J, He G. Indirect virus transmission in cluster of COVID-19 cases, Wenzhou, China, 2020. Emerg Infect Dis 2020; 26(6): 1343-5.
[http://dx.doi.org/10.3201/eid2606.200412] [PMID: 32163030]
[5]
Rodriguez-Morales AJ, Cardona-Ospina JA, Gutiérrez-Ocampo E, et al. Latin American Network of Coronavirus Disease 2019-COVID-19 Research (LANCOVID-19). Electronic address: https://www.lancovid.org Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis. Travel Med Infect Dis 342020; 101623.2020; Available; https://www.lancovid.org
[http://dx.doi.org/10.1016/j.tmaid.2020.101623]
[6]
Corman VM, Landt O, Kaiser M, et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill 2020; 25(3): 2000045.
[http://dx.doi.org/10.2807/1560-7917.ES.2020.25.3.2000045] [PMID: 31992387]
[7]
Ai T, Yang Z, Hou H, et al. Correlation of chest CT and RT-PCR testing for coronavirus disease 2019 (COVID-19) in China: A report of 1014 cases. Radiology 2020; 296(2): E32-40.
[http://dx.doi.org/10.1148/radiol.2020200642] [PMID: 32101510]
[8]
Zou L, Ruan F, Huang M, et al. SARS-CoV-2 viral load in upper respiratory specimens of infected patients. N Engl J Med 2020; 382(12): 1177-9.
[http://dx.doi.org/10.1056/NEJMc2001737] [PMID: 32074444]
[9]
Raghu G, Remy-Jardin M, Myers JL, et al. Diagnosis of idiopathic pulmonary fibrosis. An official ATS/ERS/JRS/ALAT clinical practice guideline. Am J Respir Crit Care Med 2018; 198(5): e44-68.
[http://dx.doi.org/10.1164/rccm.201807-1255ST] [PMID: 30168753]
[10]
Bai HX, Hsieh B, Xiong Z, et al. Performance of radiologists in differentiating COVID-19 from Non-COVID-19 viral pneumonia at chest CT. Radiology 2020; 296(2): E46-54.
[http://dx.doi.org/10.1148/radiol.2020200823] [PMID: 32155105]
[11]
Wang Y, Dong C, Hu Y, et al. Temporal changes of CT findings in 90 patients with COVID-19 pneumonia: A longitudinal study. Radiology 2020; 296(2): E55-64.
[http://dx.doi.org/10.1148/radiol.2020200843] [PMID: 32191587]
[12]
Wölfel R, Corman VM, Guggemos W, et al. Virological assessment of hospitalized patients with COVID-2019. Nature 2020; 581(7809): 465-9.
[http://dx.doi.org/10.1038/s41586-020-2196-x] [PMID: 32235945]
[13]
Liu Y, Yan LM, Wan L, et al. Viral dynamics in mild and severe cases of COVID-19. Lancet Infect Dis 2020; 20(6): 656-7.
[http://dx.doi.org/10.1016/S1473-3099(20)30232-2] [PMID: 32199493]
[14]
Yuan M, Yin W, Tao Z, Tan W, Hu Y. Association of radiologic findings with mortality of patients infected with 2019 novel coronavirus in Wuhan, China. PLoS One 2020; 15(3): e0230548.
[http://dx.doi.org/10.1371/journal.pone.0230548] [PMID: 32191764]
[15]
Huang EP, Sung CW, Chen CH, Fan CY, Lai PC, Huang YT. Can computed tomography be a primary tool for COVID-19 detection? Evidence appraisal through meta-analysis. Crit Care 2020; 24(1): 193.
[http://dx.doi.org/10.1186/s13054-020-02908-4] [PMID: 32375883]
[16]
Chan LL, Tan EK. Evidence of added value of chest CT in coronavirus disease (COVID-19) pneumonia with initial negative RT-PCR results. AJR Am J Roentgenol 2020; 215(3): W41.
[http://dx.doi.org/10.2214/AJR.20.23815] [PMID: 32559115]
[17]
Wang Y, Hou H, Wang W, Wang W. Combination of CT and RT-PCR in the screening or diagnosis of COVID-19. J Glob Health 2020; 10(1): 010347.
[http://dx.doi.org/10.7189/jogh.10.010347] [PMID: 32373325]
[18]
Hani C, Trieu NH, Saab I, et al. COVID-19 pneumonia: A review of typical CT findings and differential diagnosis. Diagn Interv Imaging 2020; 101(5): 263-8.
[http://dx.doi.org/10.1016/j.diii.2020.03.014] [PMID: 32291197]
[19]
Yang W, Yan F. Patients with RT-PCR-confirmed COVID-19 and Normal Chest CT. Radiology 2020; 295(2): E3.
[http://dx.doi.org/10.1148/radiol.2020200702] [PMID: 32142398]
[20]
Koo HJ, Lim S, Choe J, Choi SH, Sung H, Do KH. Radiographic and CT features of viral pneumonia. Radiographics 2018; 38(3): 719-39.
[http://dx.doi.org/10.1148/rg.2018170048] [PMID: 29757717]
[21]
Kim EA, Lee KS, Primack SL, et al. Viral pneumonias in adults: Radiologic and pathologic findings. Radiographics 2002; 22(Spec No) (Suppl. 1): S137-49.
[http://dx.doi.org/10.1148/radiographics.22.suppl_1.g02oc15s137] [PMID: 12376607]
[22]
Vabret N, Britton GJ, Gruber C, et al. Immunology of COVID-19: Current state of the science. Immunity 2020; 52(6): 910-41.
[http://dx.doi.org/10.1016/j.immuni.2020.05.002] [PMID: 32505227]
[23]
Braun J, Loyal L, Frentsch M, et al. SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19. Nature 2020; 587(7833): 270-4.
[http://dx.doi.org/10.1038/s41586-020-2598-9] [PMID: 32726801]
[24]
Sekine T, Perez-Potti A, Rivera-Ballesteros O, et al. Robust T. Cell immunity in convalescent individuals with asymptomatic or Mild COVID-19. Cell 2020; 183(1): 158-168.e14.
[http://dx.doi.org/10.1016/j.cell.2020.08.017] [PMID: 32979941]
[25]
Grifoni A, Sidney J, Zhang Y, Scheuermann RH, Peters B, Sette A. A sequence homology and bioinformatic approach can predict candidate targets for immune responses to SARS-CoV-2. Cell Host Microbe 2020; 27(4): 671-680.e2.
[http://dx.doi.org/10.1016/j.chom.2020.03.002] [PMID: 32183941]
[26]
Chen G, Wu D, Guo W, et al. Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest 2020; 130(5): 2620-9.
[http://dx.doi.org/10.1172/JCI137244] [PMID: 32217835]
[27]
Liu J, Li S, Liu J, et al. Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients. EBioMedicine 2020; 55: 102763.
[http://dx.doi.org/10.1016/j.ebiom.2020.102763] [PMID: 32361250]
[28]
Kumar P, Erturk VS, Murillo-Arcila M. A new fractional mathematical modelling of COVID-19 with the availability of vaccine. Results Phys 2021; 24: 104213.
[http://dx.doi.org/10.1016/j.rinp.2021.104213] [PMID: 33898210]
[29]
Kumar P, Erturk VS, Murillo-Arcila M, Banerjee R, Manickam A. A case study of 2019-nCOV cases in Argentina with the real data based on daily cases from March 03, 2020 to March 29, 2021 using classical and fractional derivatives. Adv Differ Equ 2021; 2021(1): 341.
[http://dx.doi.org/10.1186/s13662-021-03499-2] [PMID: 34306044]

Rights & Permissions Print Cite
Article Metrics
3
© 2024 Bentham Science Publishers | Privacy Policy